$ACFN
ACORN ENERGY, INC.

2024 Q4 Form 10-Q Financial Statement

#000149315224043923 Filed on November 07, 2024

View on sec.gov

Income Statement

Concept 2024 Q4 2024 Q3
Revenue $3.050M
YoY Change 46.14%
Cost Of Revenue $863.0K
YoY Change 60.71%
Gross Profit $2.187M
YoY Change 41.1%
Gross Profit Margin 71.7%
Selling, General & Admin $1.197M
YoY Change -10.0%
% of Gross Profit 54.73%
Research & Development $234.0K
YoY Change 10.38%
% of Gross Profit 10.7%
Depreciation & Amortization $33.00K
YoY Change -19.51%
% of Gross Profit 1.51%
Operating Expenses $1.431M
YoY Change -7.2%
Operating Profit $756.0K
YoY Change 9350.0%
Interest Expense $20.00K
YoY Change 0.0%
% of Operating Profit 2.65%
Other Income/Expense, Net
YoY Change
Pretax Income $776.0K
YoY Change 2774.07%
Income Tax $42.00K
% Of Pretax Income 5.41%
Net Earnings $725.0K
YoY Change 2920.83%
Net Earnings / Revenue 23.77%
Basic Earnings Per Share $0.29
Diluted Earnings Per Share $0.29
COMMON SHARES
Basic Shares Outstanding 2.488M shares 2.487M shares
Diluted Shares Outstanding 2.511M shares

Balance Sheet

Concept 2024 Q4 2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.153M
YoY Change 26.65%
Cash & Equivalents $2.153M
Short-Term Investments
Other Short-Term Assets $318.0K
YoY Change -7.29%
Inventory $659.0K
Prepaid Expenses
Receivables $894.0K
Other Receivables $0.00
Total Short-Term Assets $4.531M
YoY Change 1.27%
LONG-TERM ASSETS
Property, Plant & Equipment $527.0K
YoY Change -13.61%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $99.00K
YoY Change -52.63%
Total Long-Term Assets $872.0K
YoY Change -48.13%
TOTAL ASSETS
Total Short-Term Assets $4.531M
Total Long-Term Assets $872.0K
Total Assets $5.403M
YoY Change -12.22%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $313.0K
YoY Change -29.5%
Accrued Expenses $202.0K
YoY Change 59.06%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $4.254M
YoY Change -14.7%
LONG-TERM LIABILITIES
Long-Term Debt $0.00
YoY Change
Other Long-Term Liabilities $23.00K
YoY Change 21.05%
Total Long-Term Liabilities $23.00K
YoY Change -98.9%
TOTAL LIABILITIES
Total Short-Term Liabilities $4.254M
Total Long-Term Liabilities $23.00K
Total Liabilities $5.089M
YoY Change -28.08%
SHAREHOLDERS EQUITY
Retained Earnings -$100.1M
YoY Change -1.13%
Common Stock $103.4M
YoY Change 0.07%
Preferred Stock
YoY Change
Treasury Stock (at cost) $3.036M
YoY Change 0.0%
Treasury Stock Shares
Shareholders Equity $288.0K
YoY Change
Total Liabilities & Shareholders Equity $5.403M
YoY Change -12.22%

Cashflow Statement

Concept 2024 Q4 2024 Q3
OPERATING ACTIVITIES
Net Income $725.0K
YoY Change 2920.83%
Depreciation, Depletion And Amortization $33.00K
YoY Change -19.51%
Cash From Operating Activities $698.0K
YoY Change 232.38%
INVESTING ACTIVITIES
Capital Expenditures $4.000K
YoY Change -86.67%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$4.000K
YoY Change -86.67%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change
NET CHANGE
Cash From Operating Activities 698.0K
Cash From Investing Activities -4.000K
Cash From Financing Activities 0.000
Net Change In Cash 694.0K
YoY Change 285.56%
FREE CASH FLOW
Cash From Operating Activities $698.0K
Capital Expenditures $4.000K
Free Cash Flow $694.0K
YoY Change 285.56%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
usd
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2532000 shares
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2484000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2485000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2511000 shares
CY2024Q3 us-gaap Inventory Net
InventoryNet
659000 usd
CY2024Q3 us-gaap Deferred Costs Current
DeferredCostsCurrent
507000 usd
CY2024Q3 us-gaap Other Assets Current
OtherAssetsCurrent
318000 usd
CY2024Q3 us-gaap Assets Current
AssetsCurrent
4531000 usd
dei Entity Central Index Key
EntityCentralIndexKey
0000880984
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-09-30
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
001-33886
dei Entity Registrant Name
EntityRegistrantName
ACORN ENERGY, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
22-2786081
dei Entity Address Address Line1
EntityAddressAddressLine1
1000 N West Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 1200
dei Entity Address City Or Town
EntityAddressCityOrTown
Wilmington
dei Entity Address State Or Province
EntityAddressStateOrProvince
DE
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
19801
dei City Area Code
CityAreaCode
770
dei Local Phone Number
LocalPhoneNumber
209-0012
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
527000 usd
CY2024Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
112000 usd
CY2024Q3 us-gaap Deferred Costs
DeferredCosts
134000 usd
CY2024Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
99000 usd
CY2024Q3 us-gaap Assets
Assets
5403000 usd
CY2024Q3 us-gaap Accounts Payable Current
AccountsPayableCurrent
313000 usd
CY2024Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
202000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3572000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
129000 usd
CY2024Q3 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
38000 usd
CY2024Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4254000 usd
CY2024Q3 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
23000 usd
CY2024Q3 us-gaap Liabilities
Liabilities
5089000 usd
CY2024Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103386000 usd
CY2024Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-100087000 usd
CY2024Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5403000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7457000 usd
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
CY2023Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
536000 usd
CY2023Q4 us-gaap Deferred Costs Current
DeferredCostsCurrent
809000 usd
CY2023Q4 us-gaap Other Assets Current
OtherAssetsCurrent
280000 usd
CY2023Q4 us-gaap Assets Current
AssetsCurrent
4036000 usd
CY2023Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
193000 usd
CY2023Q4 us-gaap Deferred Costs
DeferredCosts
476000 usd
CY2023Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
174000 usd
CY2023Q4 us-gaap Assets
Assets
5449000 usd
CY2023Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
288000 usd
CY2023Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
132000 usd
CY2023Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
4034000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
962000 usd
CY2023Q4 us-gaap Cash
Cash
1449000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
570000 usd
CY2024Q3 us-gaap Operating Expenses
OperatingExpenses
1431000 usd
CY2023Q3 us-gaap Operating Expenses
OperatingExpenses
1542000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-4000 usd
CY2024Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
756000 usd
CY2023Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
8000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
46000 usd
CY2024Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
20000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
776000 usd
us-gaap Profit Loss
ProfitLoss
42000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
734000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
27000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
7000 usd
CY2024Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
9000 usd
CY2023Q3 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
3000 usd
us-gaap Net Income Loss
NetIncomeLoss
35000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2023Q4 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
30000 usd
CY2023Q4 us-gaap Liabilities Current
LiabilitiesCurrent
4607000 usd
CY2023Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
1550000 usd
CY2023Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
98000 usd
CY2023Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
20000 usd
CY2023Q4 us-gaap Liabilities
Liabilities
6275000 usd
CY2023Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
103321000 usd
CY2023Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-101148000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826000 usd
CY2023Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5449000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5809000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3050000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2087000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
1453000 usd
CY2024Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
863000 usd
CY2023Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
537000 usd
us-gaap Gross Profit
GrossProfit
4356000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2187000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
614000 usd
CY2024Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
234000 usd
CY2023Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
212000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3746000 usd
CY2024Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1197000 usd
CY2023Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1330000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2506000 shares
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
dei Amendment Flag
AmendmentFlag
false
CY2024Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
usd
CY2024Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
CY2023Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
pure
ACFN Deferred Charges Sale Of Equipment Additions
DeferredChargesSaleOfEquipmentAdditions
usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment In Year Three
DeferredChargesSaleOfEquipmentInYearThree
usd
dei Entity Listing Par Value Per Share
EntityListingParValuePerShare
0.01
CY2024Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2488318 shares
CY2024Q3 us-gaap Cash
Cash
2153000 usd
CY2023Q4 us-gaap Cash
Cash
1449000 usd
CY2024Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
894000 usd
CY2023Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
570000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
123000 usd
CY2024Q3 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
812000 usd
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
42000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
42000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2537485 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2534969 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2487307 shares
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2484791 shares
CY2023Q4 us-gaap Common Stock Value
CommonStockValue
25000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
50178 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
50178 shares
CY2023Q4 us-gaap Treasury Stock Value
TreasuryStockValue
3036000 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
-838000 usd
CY2024Q3 us-gaap Minority Interest
MinorityInterest
26000 usd
CY2023Q4 us-gaap Minority Interest
MinorityInterest
12000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
314000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2014000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
698000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3653000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1092000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
53000 usd
CY2023Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
123000 usd
CY2023Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2024Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
42000000 shares
CY2023Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
42000000 shares
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2537485 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2534969 shares
CY2024Q3 us-gaap Common Stock Value
CommonStockValue
25000 usd
CY2024Q3 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
50178 shares
CY2023Q4 us-gaap Treasury Stock Common Shares
TreasuryStockCommonShares
50178 shares
CY2024Q3 us-gaap Treasury Stock Value
TreasuryStockValue
3036000 usd
CY2024Q3 us-gaap Stockholders Equity
StockholdersEquity
288000 usd
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
2014000 usd
us-gaap Gross Profit
GrossProfit
5443000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1550000 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
698000 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
3653000 usd
us-gaap Operating Expenses
OperatingExpenses
4351000 usd
us-gaap Operating Expenses
OperatingExpenses
4360000 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
1092000 usd
us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
53000 usd
CY2023Q3 us-gaap Interest Income Expense Net
InterestIncomeExpenseNet
19000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1145000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000 usd
us-gaap Profit Loss
ProfitLoss
1078000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000 usd
us-gaap Net Income Loss
NetIncomeLoss
1061000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2504000 shares
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1145000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27000 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
67000 usd
CY2024Q3 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
42000 usd
us-gaap Profit Loss
ProfitLoss
1078000 usd
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
17000 usd
us-gaap Net Income Loss
NetIncomeLoss
1061000 usd
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2504000 shares
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-826000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
68000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13000 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-719000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
276000 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-433000 usd
CY2024Q3 us-gaap Profit Loss
ProfitLoss
734000 usd
CY2024Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
314000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1011000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-84000 usd
CY2023Q1 ACFN Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
5000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1074000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
99000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-963000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
27000 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-921000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-921000 usd
us-gaap Profit Loss
ProfitLoss
1078000 usd
us-gaap Profit Loss
ProfitLoss
42000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
91000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
115000 usd
ACFN Decrease Increase In Provision For Credit Loss
DecreaseIncreaseInProvisionForCreditLoss
-7000 usd
ACFN Decrease Increase In Provision For Credit Loss
DecreaseIncreaseInProvisionForCreditLoss
3000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
21000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
9000 usd
ACFN Noncash Lease Expense
NoncashLeaseExpense
97000 usd
ACFN Noncash Lease Expense
NoncashLeaseExpense
96000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
52000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
46000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
351000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11000 usd
CY2024Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-719000 usd
CY2024Q2 us-gaap Profit Loss
ProfitLoss
276000 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11000 usd
CY2024Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-433000 usd
CY2024Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2024Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14000 usd
CY2024Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
314000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1011000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-84000 usd
CY2023Q1 ACFN Stock Issued During Period Value Warrant Exercise
StockIssuedDuringPeriodValueWarrantExercise
5000 usd
CY2023Q1 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
17000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1074000 usd
CY2023Q2 us-gaap Profit Loss
ProfitLoss
99000 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
13000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-963000 usd
CY2023Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-963000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
27000 usd
CY2023Q3 us-gaap Profit Loss
ProfitLoss
27000 usd
CY2023Q3 us-gaap Dividends Preferred Stock
DividendsPreferredStock
1000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
16000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-921000 usd
CY2023Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-921000 usd
us-gaap Profit Loss
ProfitLoss
1078000 usd
us-gaap Profit Loss
ProfitLoss
42000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
91000 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
115000 usd
ACFN Decrease Increase In Provision For Credit Loss
DecreaseIncreaseInProvisionForCreditLoss
-7000 usd
ACFN Decrease Increase In Provision For Credit Loss
DecreaseIncreaseInProvisionForCreditLoss
3000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
21000 usd
us-gaap Asset Impairment Charges
AssetImpairmentCharges
9000 usd
ACFN Noncash Lease Expense
NoncashLeaseExpense
97000 usd
ACFN Noncash Lease Expense
NoncashLeaseExpense
96000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
52000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
46000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
351000 usd
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-11000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-282000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129000 usd
ACFN Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-644000 usd
ACFN Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-162000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-37000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
49000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1200000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-108000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-104000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
103000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
124000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-282000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
129000 usd
ACFN Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-644000 usd
ACFN Increase Decrease In Deferred Cost Of Goods Sold
IncreaseDecreaseInDeferredCostOfGoodsSold
-162000 usd
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-37000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1200000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
40000 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-104000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
103000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
124000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
739000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
366000 usd
us-gaap Payments For Software
PaymentsForSoftware
44000 usd
us-gaap Payments For Software
PaymentsForSoftware
70000 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4000 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
704000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
299000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1450000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2153000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1749000 usd
us-gaap Interest Paid Net
InterestPaidNet
2000 usd
ACFN Accrued Preferred Dividends
AccruedPreferredDividends
3000 usd
ACFN Accrued Preferred Dividends
AccruedPreferredDividends
3000 usd
CY2023Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-16
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
347 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zNw06IFj6945" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z8nc5b9Ldgta">Use of Estimates in Preparation of Financial Statements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
739000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
366000 usd
us-gaap Payments For Software
PaymentsForSoftware
44000 usd
us-gaap Payments For Software
PaymentsForSoftware
70000 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
4000 usd
us-gaap Payments To Acquire Machinery And Equipment
PaymentsToAcquireMachineryAndEquipment
2000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-72000 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13000 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
5000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
5000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
704000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
299000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1449000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1450000 usd
CY2024Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
2153000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1749000 usd
us-gaap Interest Paid Net
InterestPaidNet
1000 usd
us-gaap Interest Paid Net
InterestPaidNet
2000 usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
2000 usd
ACFN Accrued Preferred Dividends
AccruedPreferredDividends
3000 usd
ACFN Accrued Preferred Dividends
AccruedPreferredDividends
3000 usd
CY2023Q3 us-gaap Stockholders Equity Reverse Stock Split
StockholdersEquityReverseStockSplit
1-for-16
CY2023Q3 us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
347 usd
us-gaap Use Of Estimates
UseOfEstimates
<p id="xdx_84C_eus-gaap--UseOfEstimates_zNw06IFj6945" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_869_z8nc5b9Ldgta">Use of Estimates in Preparation of Financial Statements</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The preparation of unaudited condensed consolidated financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities as of the date of the unaudited condensed consolidated financial statements, and the reported amounts of revenues and expenses during the reporting periods. Actual results could differ from those estimates.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"></p>
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zqw8NrP0Y9H" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zzjILDxSNVa4">Concentrations of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_90C_eus-gaap--DepositAssets_iI_c20240930_zk1rygyxb7Je" title="Deposits assets">2,153,000</span> at September 30, 2024. The Company does not believe there is a significant risk of non-performance by its counterparties. For the nine- and three-month period ended September 30, 2024, there was one customer that represented <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zrrL3Q8lTtcc" title="Concentration risk percentage">12</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zEyQVXFTT8yd" title="Concentration risk percentage">26</span>%, respectively, of the Company’s total invoiced sales. At September 30, 2024, the Company had one customer that represented <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zu9E5VyHjJpc" title="Concentration risk percentage">37</span>% of its total accounts receivable due by December 29, 2024 based on the customer’s payment terms. The customer with this concentration of both invoiced sales and accounts receivable is the customer under the material contract that was executed in June 2024. See Note 10 for further discussion. Approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zP2BEw3SQIa2" title="Concentration risk percentage">25</span>% of the accounts receivable at December 31, 2023 was due from one customer which was subsequently collected in full. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising the Company’s customer base. Although we do not believe there is significant risk of non-performance by these counterparties, any failures or defaults on their part could negatively impact the value of our financial instruments and could have a material adverse effect on our business, operations or financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Deposit Assets
DepositAssets
2153000 usd
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p id="xdx_842_eus-gaap--ConcentrationRiskCreditRisk_zqw8NrP0Y9H" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86D_zzjILDxSNVa4">Concentrations of Credit Risk</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">Financial instruments, which potentially subject the Company to concentrations of credit risk, consist principally of cash and trade accounts receivable. The Company’s cash was deposited with a U.S. bank and amounted to $<span id="xdx_90C_eus-gaap--DepositAssets_iI_c20240930_zk1rygyxb7Je" title="Deposits assets">2,153,000</span> at September 30, 2024. The Company does not believe there is a significant risk of non-performance by its counterparties. For the nine- and three-month period ended September 30, 2024, there was one customer that represented <span id="xdx_902_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zrrL3Q8lTtcc" title="Concentration risk percentage">12</span>% and <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240701__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--SalesRevenueNetMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zEyQVXFTT8yd" title="Concentration risk percentage">26</span>%, respectively, of the Company’s total invoiced sales. At September 30, 2024, the Company had one customer that represented <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20240101__20240930__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zu9E5VyHjJpc" title="Concentration risk percentage">37</span>% of its total accounts receivable due by December 29, 2024 based on the customer’s payment terms. The customer with this concentration of both invoiced sales and accounts receivable is the customer under the material contract that was executed in June 2024. See Note 10 for further discussion. Approximately <span id="xdx_90A_eus-gaap--ConcentrationRiskPercentage1_pid_dp_uPure_c20230101__20231231__us-gaap--ConcentrationRiskByBenchmarkAxis__us-gaap--AccountsReceivableMember__us-gaap--ConcentrationRiskByTypeAxis__us-gaap--CustomerConcentrationRiskMember__srt--ProductOrServiceAxis__custom--OneCustomerMember_zP2BEw3SQIa2" title="Concentration risk percentage">25</span>% of the accounts receivable at December 31, 2023 was due from one customer which was subsequently collected in full. Credit risk with respect to the balance of trade receivables is generally diversified due to the number of entities comprising the Company’s customer base. Although we do not believe there is significant risk of non-performance by these counterparties, any failures or defaults on their part could negatively impact the value of our financial instruments and could have a material adverse effect on our business, operations or financial condition.</span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0pt 0pt 0; text-align: justify; text-indent: 0.5in"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p>
CY2024Q3 us-gaap Deposit Assets
DepositAssets
2153000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17000 shares
ACFN Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
9.09
CY2024Q3 ACFN Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
9.17
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Net Income Loss
NetIncomeLoss
1061000 usd
us-gaap Net Income Loss
NetIncomeLoss
35000 usd
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
17000 shares
ACFN Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
9.09
CY2024Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
15000 shares
CY2024Q3 ACFN Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
9.17
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6000 shares
ACFN Antidilutive Securities Excluded From Computation Of Earnings Per Share Weighted Average Exercise Price
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareWeightedAverageExercisePrice
8.49
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
0 shares
us-gaap Net Income Loss
NetIncomeLoss
1061000 usd
us-gaap Net Income Loss
NetIncomeLoss
35000 usd
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2484000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2485000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
47000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2504000 shares
CY2024Q3 us-gaap Net Income Loss
NetIncomeLoss
725000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
24000 usd
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2484000 shares
CY2024Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2487000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2485000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
17000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
22000 shares
CY2024Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
24000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
47000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2504000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2506000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2511000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2532000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2153000 usd
CY2024Q3 ACFN Working Capital
WorkingCapital
-277000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2153000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3572000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1200000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
704000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
739000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13000 usd
CY2024Q4 us-gaap Cash
Cash
2087000 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
900000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6000 usd
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2506000 shares
CY2024Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2511000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2532000 shares
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.43
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
CY2024Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.01
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.42
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.01
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2153000 usd
CY2024Q3 ACFN Working Capital
WorkingCapital
-277000 usd
CY2024Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2153000 usd
CY2024Q3 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
3572000 usd
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1200000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
704000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
739000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-48000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
13000 usd
CY2024Q4 us-gaap Cash
Cash
2087000 usd
CY2024Q3 us-gaap Accounts Receivable Net
AccountsReceivableNet
900000 usd
CY2024Q3 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
6000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-7000 usd
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2000 usd
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-3000 usd
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
2000 usd
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10000 usd
CY2022Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10000 usd
us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
-7000 usd
CY2023 us-gaap Provision For Loan Lease And Other Losses
ProvisionForLoanLeaseAndOtherLosses
2000 usd
us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
-3000 usd
CY2023 us-gaap Financing Receivable Allowance For Credit Losses Period Increase Decrease
FinancingReceivableAllowanceForCreditLossesPeriodIncreaseDecrease
2000 usd
CY2024Q3 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
6000 usd
CY2023Q4 us-gaap Financing Receivable Allowance For Credit Losses
FinancingReceivableAllowanceForCreditLosses
10000 usd
CY2024Q3 us-gaap Inventory Raw Materials
InventoryRawMaterials
586000 usd
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
904000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
73000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
58000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
962000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
11000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
8000 usd
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.045 pure
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
129000 usd
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.045 pure
CY2023Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
904000 usd
CY2024Q3 us-gaap Inventory Finished Goods
InventoryFinishedGoods
73000 usd
CY2023Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
58000 usd
CY2024Q3 us-gaap Inventory Net
InventoryNet
659000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
962000 usd
CY2024Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
11000 usd
CY2023Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
8000 usd
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.045 pure
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
129000 usd
CY2024Q3 us-gaap Lessee Operating Lease Discount Rate
LesseeOperatingLeaseDiscountRate
0.045 pure
ACFN Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
97000 usd
ACFN Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
96000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
ACFN Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
97000 usd
ACFN Cash Paid For Operating Lease Liabilities
CashPaidForOperatingLeaseLiabilities
96000 usd
CY2024Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P1Y
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
132000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
132000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
129000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
129000 usd
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
2375 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
7000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
7000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
0 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
0 usd
ACFN Sublease Profit Paid
SubleaseProfitPaid
16000 usd
ACFN Sublease Profit Paid
SubleaseProfitPaid
16000 usd
CY2024Q3 ACFN Accrued Sublease Profit
AccruedSubleaseProfit
2000 usd
CY2021Q3 ACFN Annual Service Cost
AnnualServiceCost
2000 usd
CY2024Q3 ACFN Finance Lease Liability Sublease Payments Due Next Twelve Months
FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths
29000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
132000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
132000 usd
CY2024Q3 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
3000 usd
CY2024Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
129000 usd
CY2024Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
129000 usd
CY2021Q3 us-gaap Sublease Income
SubleaseIncome
2375 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
7000 usd
CY2024Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
7000 usd
us-gaap Operating Lease Payments
OperatingLeasePayments
0 usd
CY2023Q3 us-gaap Operating Lease Payments
OperatingLeasePayments
0 usd
ACFN Sublease Profit Paid
SubleaseProfitPaid
16000 usd
ACFN Sublease Profit Paid
SubleaseProfitPaid
16000 usd
CY2024Q3 ACFN Accrued Sublease Profit
AccruedSubleaseProfit
2000 usd
CY2021Q3 ACFN Annual Service Cost
AnnualServiceCost
2000 usd
CY2024Q3 ACFN Finance Lease Liability Sublease Payments Due Next Twelve Months
FinanceLeaseLiabilitySubleasePaymentsDueNextTwelveMonths
29000 usd
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2537485 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2487307 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
71893 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.41
CY2023 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y9M18D
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
40000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
7900 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.08
CY2024Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
2537485 shares
CY2024Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
2487307 shares
CY2024Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.01
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
71893 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
40000 usd
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
6.08
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2812 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.12
ACFN Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPeriod
-1104 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.67
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75877 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
251000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
69341 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.47
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
227000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.941 pure
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7457000 usd
us-gaap Gross Profit
GrossProfit
5443000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91000 usd
ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
1915000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5809000 usd
us-gaap Gross Profit
GrossProfit
4356000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
115000 usd
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2812 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
5.12
ACFN Share Based Compensation Arrangement By Share Based Payment Award Option Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionForfeituresAndExpirationsInPeriod
-1104 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
5.67
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
75877 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
6.43
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P3Y6M
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
251000 usd
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
69341 shares
CY2024Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
6.47
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P3Y3M18D
CY2024Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
227000 usd
ACFN Fair Value Of Options Granted
FairValueOfOptionsGranted
47000 usd
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.039 pure
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P4Y10M24D
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.941 pure
CY2024Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17000 usd
CY2023Q3 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
17000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
2 segments
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7457000 usd
us-gaap Gross Profit
GrossProfit
5443000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
91000 usd
ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
1915000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5809000 usd
us-gaap Gross Profit
GrossProfit
4356000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
115000 usd
ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
856000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3050000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2187000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33000 usd
CY2024Q3 ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
1012000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2087000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1550000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41000 usd
CY2023Q3 ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
366000 usd
ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
856000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3050000 usd
CY2024Q3 us-gaap Gross Profit
GrossProfit
2187000 usd
CY2024Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
33000 usd
CY2024Q3 ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
1012000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2087000 usd
CY2023Q3 us-gaap Gross Profit
GrossProfit
1550000 usd
CY2023Q3 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
41000 usd
CY2023Q3 ACFN Segment Income Loss Before Income Taxes
SegmentIncomeLossBeforeIncomeTaxes
366000 usd
ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
1915000 usd
ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
856000 usd
CY2024Q3 ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
1012000 usd
ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
770000 usd
ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
814000 usd
CY2024Q3 ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
236000 usd
CY2023Q3 ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
339000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1145000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
776000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7457000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5809000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3050000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2087000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5584000 usd
ACFN Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3613000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-4813000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4384000 usd
ACFN Contract With Customer Liability Revenue Additions In Year One
ContractWithCustomerLiabilityRevenueAdditionsInYearOne
3572000 usd
ACFN Contract With Customer Liability Revenue Additions In Year Two
ContractWithCustomerLiabilityRevenueAdditionsInYearTwo
809000 usd
ACFN Contract With Customer Liability Revenue Additions In Year Three
ContractWithCustomerLiabilityRevenueAdditionsInYearThree
3000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4384000 usd
ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
1915000 usd
ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
856000 usd
CY2024Q3 ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
1012000 usd
CY2023Q3 ACFN Net Income Loss Before Income Taxes For Reportable Segments
NetIncomeLossBeforeIncomeTaxesForReportableSegments
366000 usd
ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
770000 usd
ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
814000 usd
CY2024Q3 ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
236000 usd
CY2023Q3 ACFN Unallocated Cost Of Corporate Headquarters
UnallocatedCostOfCorporateHeadquarters
339000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
1145000 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
42000 usd
CY2024Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
776000 usd
CY2023Q3 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
27000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
7457000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
5809000 usd
CY2024Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3050000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
2087000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
5584000 usd
ACFN Contract With Customer Liability Additions
ContractWithCustomerLiabilityAdditions
3613000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
-4813000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4384000 usd
ACFN Contract With Customer Liability Revenue Additions In Year One
ContractWithCustomerLiabilityRevenueAdditionsInYearOne
3572000 usd
ACFN Contract With Customer Liability Revenue Additions In Year Two
ContractWithCustomerLiabilityRevenueAdditionsInYearTwo
809000 usd
ACFN Contract With Customer Liability Revenue Additions In Year Three
ContractWithCustomerLiabilityRevenueAdditionsInYearThree
3000 usd
CY2024Q3 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
4384000 usd
CY2023Q4 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
1285000 usd
ACFN Deferred Charges Sale Of Equipment Recognized
DeferredChargesSaleOfEquipmentRecognized
-644000 usd
CY2024Q3 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
641000 usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment In Year One
DeferredChargesSaleOfEquipmentInYearOne
507000 usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment In Year Two
DeferredChargesSaleOfEquipmentInYearTwo
134000 usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment
DeferredChargesSaleOfEquipment
641000 usd
CY2023Q4 ACFN Contract With Customer Asset Sale Commission
ContractWithCustomerAssetSaleCommission
364000 usd
ACFN Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
35000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
163000 usd
CY2024Q3 ACFN Contract With Customer Asset Sale Commission
ContractWithCustomerAssetSaleCommission
236000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense In Year One
ContractWithCustomerLiabilitySalesCommissionsExpenseInYearOne
150000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense In Year Two
ContractWithCustomerLiabilitySalesCommissionsExpenseInYearTwo
63000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense In Year Three
ContractWithCustomerLiabilitySalesCommissionsExpenseInYearThree
23000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense
ContractWithCustomerLiabilitySalesCommissionsExpense
236000 usd
CY2023Q4 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
1285000 usd
ACFN Deferred Charges Sale Of Equipment Recognized
DeferredChargesSaleOfEquipmentRecognized
-644000 usd
CY2024Q3 us-gaap Deferred Sales Inducements Net
DeferredSalesInducementsNet
641000 usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment In Year One
DeferredChargesSaleOfEquipmentInYearOne
507000 usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment In Year Two
DeferredChargesSaleOfEquipmentInYearTwo
134000 usd
CY2024Q3 ACFN Deferred Charges Sale Of Equipment
DeferredChargesSaleOfEquipment
641000 usd
CY2023Q4 ACFN Contract With Customer Asset Sale Commission
ContractWithCustomerAssetSaleCommission
364000 usd
ACFN Contract With Customer Asset Additions
ContractWithCustomerAssetAdditions
35000 usd
us-gaap Amortization Of Deferred Sales Commissions
AmortizationOfDeferredSalesCommissions
163000 usd
CY2024Q3 ACFN Contract With Customer Asset Sale Commission
ContractWithCustomerAssetSaleCommission
236000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense In Year One
ContractWithCustomerLiabilitySalesCommissionsExpenseInYearOne
150000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense In Year Two
ContractWithCustomerLiabilitySalesCommissionsExpenseInYearTwo
63000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense In Year Three
ContractWithCustomerLiabilitySalesCommissionsExpenseInYearThree
23000 usd
CY2024Q3 ACFN Contract With Customer Liability Sales Commissions Expense
ContractWithCustomerLiabilitySalesCommissionsExpense
236000 usd

Files In Submission

Name View Source Status
acfn-20240930_lab.xml Edgar Link unprocessable
0001493152-24-043923-index-headers.html Edgar Link pending
0001493152-24-043923-index.html Edgar Link pending
0001493152-24-043923.txt Edgar Link pending
0001493152-24-043923-xbrl.zip Edgar Link pending
acfn-20240930.xsd Edgar Link pending
ex31-1.htm Edgar Link pending
ex31-2.htm Edgar Link pending
ex32-1.htm Edgar Link pending
ex32-2.htm Edgar Link pending
Financial_Report.xlsx Edgar Link pending
form10-q.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
acfn-20240930_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
acfn-20240930_cal.xml Edgar Link unprocessable
form10-q_htm.xml Edgar Link completed
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
acfn-20240930_def.xml Edgar Link unprocessable